Your European Patent (EP) does not automatically deliver Europe-wide protection on grant. Instead, your EP will need to be validated in one or more of the member states of the European Patent Convention. In 2023, the option of covering a large number of the member states with a single ‘unitary patent’ became available. Validation is something our highly efficient and experienced in-house validation team can manage for you.
The team has a wealth of experience in managing the validation process on behalf of our clients using our network of handpicked and reliable local associates, built up over many years. We also have a bank of trusted translators chosen for their expertise in accurately translating the often highly technical language of patent specifications. We do not recommend that translators unfamiliar with patents are used, since an inaccurate translation can have a serious effect on the patent protection.
Our IP experts can manage the entire patent application process from filing to examination and grant to validation all under one roof. Paying renewal fees to extend the life of your patent as well as dealing with any disputes along the way should they arise. Our streamlined service offering is underpinned by our case management system, which manages all our client information and case data. Designed to save time and money, enable scale and reduce risk it is client focussed and puts our clients at the heart of our business, enabling us to be flexible to your needs.
Read our Law and Practice guides on the European Grant Procedure and Designation, Extension and Validation States for European Patent Applications for more detail.
You can download a copy of our Validation Strategies for Pharmaceutical Patents in Europe Special Report 2021 here. This report also includes a 2022 addendum that covers the UP and UPC.
